Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Abstract Text:

David B Seligson,Fumiya Hongo,Sara Huerta-Yepez,Yoichi Mizutani,Tsuneharu Miki,Hong Yu,Steve Horvath,David Chia,Lee Goodglick,Benjamin Bonavida,David B Seligson,Fumiya Hongo,Sara Huerta-Yepez,Yoichi Mizutani,Tsuneharu Miki,Hong Yu,Steve Horvath,David Chia,Lee Goodglick,Benjamin Bonavida,

PURPOSE: The X-linked inhibitor of apoptosis protein (XIAP) is associated with cell survival by blocking caspase-mediated apoptosis. We examined the expression patterns of XIAP with regard to human prostate cancer, predicting that XIAP status may predict cancer recurrence and/or clinical outcome. EXPERIMENTAL DESIGN: Immunohistochemistry was done on tissue microarrays constructed from 226 primary prostate cancer specimen. The protein expression distribution was examined across the spectrum of epithelial tissues and its association with standard clinicopathologic covariates and tumor recurrence was examined in 192 outcome-informative patients. RESULTS: The mean XIAP expression was significantly higher in prostate cancer compared with prostatic intraepithelial neoplasia (PIN), normal, and benign prostatic hyperplasia. We observed that XIAP is an independent predictor of tumor recurrence in multivariate Cox proportional hazards analysis in all patients as well as after substratifying by Gleason score. Interestingly, patients with high XIAP levels had a much lower probability of tumor recurrence than those with lower XIAP expression. Even patients with high-grade tumors who had higher XIAP levels had a lower risk of recurrence compared with any patient whose tumors express lower XIAP. CONCLUSIONS: XIAP is expressed at higher levels in prostate cancers compared with matched normal tissues. High XIAP expression is strongly associated with a reduced risk of tumor recurrence and is not directly associated with Gleason score, tumor stage, capsular involvement, or preoperative prostate-specific antigen status, suggesting that it is a novel prognosticator and a potential target for prostate cancer diagnosis and therapy. Significantly, these findings provide important and extensive validation of previous results.

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Publishing Authors By Initials

DB Seligson,F Hongo,S Huerta-Yepez,Y Mizutani,T Miki,H Yu,S Horvath,D Chia,L Goodglick,B Bonavida,DB Seligson,F Hongo,S Huerta-Yepez,Y Mizutani,T Miki,H Yu,S Horvath,D Chia,L Goodglick,B Bonavida,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Clinical cancer research : an official journal of

VOLUME: 13

Page Numbers: 6056-63

Journal Abbreviation: Clin. Cancer Res.

ISSN: 1078-0432

DAY: 15

MONTH: Oct

YEAR: 2007

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502500

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

AFFILIATION: Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California 90095-1747, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA-86366

ACRONYM: CA

MEDLINETA: Clin Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence Related Publications

• Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
• Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
• Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
• Inhibition of Yin Yang 1-Dependent Repressor Activity of DR5 Transcription and Expression by the Novel Proteasome Inhibitor NPI-0052 Contributes to its TRAIL-Enhanced Apoptosis in Cancer Cells.
• Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
• Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
• Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
• Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
• X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondr